Return to homepagePandemic Pact

Clonal haematopoiesis and Covid-19 disease severity

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-370

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    George Vassiliou

  • Research Location

    United Kingdom

  • Lead Research Institution

    Wellcome - Medical Research Council Cambridge Stem Cell Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Professor George Vassiliou's lab are investigating the hypothesis that clonal haematopoiesis may be linked to increased severity of Covid-19, if proven this would transform disease understanding, help identify at-risk individuals and support immediate initiation of relevant therapeutic approaches. The team have received a European Hematology Association COVID-19 in Hematology Research Grant for their project.